Translating tolerogenic therapies to the clinic - where do we stand?
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early...
Päätekijät: | Issa, F, Wood, K |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2012
|
Samankaltaisia teoksia
-
Translating tolerogenic therapies to the clinic – where do we stand?
Tekijä: Fadi eIssa, et al.
Julkaistu: (2012-08-01) -
Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?
Tekijä: Cobbold, S, et al.
Julkaistu: (2012) -
Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
Tekijä: Stephen Paul Cobbold, et al.
Julkaistu: (2012-10-01) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
Tekijä: Eros Marín, et al.
Julkaistu: (2018-02-01) -
Clinical Microbiology: where do we stand?
Tekijä: Alkiviadis Vatopoulos
Julkaistu: (2024-06-01)